168 related articles for article (PubMed ID: 34382653)
1. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.
Giovanella L; Garo ML; Ceriani L; Paone G; Campenni' A; D'Aurizio F
J Clin Endocrinol Metab; 2021 Nov; 106(12):3634-3643. PubMed ID: 34382653
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Trimboli P; Giovanella L
Endocrinol Metab (Seoul); 2018 Jun; 33(2):204-210. PubMed ID: 29947178
[TBL] [Abstract][Full Text] [Related]
4. Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows.
Censi S; Di Stefano M; Repaci A; Benvenuti T; Manso J; Pagotto U; Iacobone M; Barollo S; Bertazza L; Galuppini F; Benna C; Pennelli G; Plebani M; Faggian D; Colombo C; Fugazzola L; Mian C
Front Endocrinol (Lausanne); 2021; 12():754565. PubMed ID: 34721303
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
Verbeek HH; de Groot JWB; Sluiter WJ; Muller Kobold AC; van den Heuvel ER; Plukker JT; Links TP
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010159. PubMed ID: 32176812
[TBL] [Abstract][Full Text] [Related]
6. The role of procalcitonin in the follow-up of medullary thyroid cancer.
Censi S; Manso J; Benvenuti T; Piva I; Iacobone M; Mondin A; Torresan F; Basso D; Crivellari G; Zovato S; Mian C
Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36476491
[TBL] [Abstract][Full Text] [Related]
7. Salivary and serum biomarkers of inflammation in a man with metastatic medullary thyroid carcinoma and hyperreactive gingiva: a fourteen year odyssey.
Redman RS; Bayley NC; Nylén ES
Biotech Histochem; 2019 Aug; 94(6):389-397. PubMed ID: 31423894
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of calcitonin and procalcitonin Elecsys
Giovanella L; Fontana M; Keller F; Verburg FA; Ceriani L
Clin Chem Lab Med; 2021 Mar; 59(4):743-747. PubMed ID: 33085633
[TBL] [Abstract][Full Text] [Related]
10. False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
Takeshima K; Ariyasu H; Uraki S; Morita S; Furukawa Y; Inaba H; Iwakura H; Doi A; Warigaya K; Murata SI; Enomoto K; Hotomi M; Akamizu T
Endocr J; 2020 Oct; 67(10):1007-1017. PubMed ID: 32522910
[TBL] [Abstract][Full Text] [Related]
11. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
12. Novel acquisitions in the diagnosis of medullary thyroid carcinoma.
Trimboli P; Crescenzi A; Saggiorato E; Treglia G; Giovanella L
Minerva Endocrinol; 2017 Sep; 42(3):238-247. PubMed ID: 27808486
[TBL] [Abstract][Full Text] [Related]
13. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
Trimboli P; Giovanella L
Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
[TBL] [Abstract][Full Text] [Related]
15. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
Ittner L; Born W; Rau B; Steinbach G; Fischer JA
Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
[TBL] [Abstract][Full Text] [Related]
16. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
17. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
Kartal Baykan E; Erdoğan M
Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
19. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
Karagiannis AK; Girio-Fragkoulakis C; Nakouti T
Anticancer Res; 2016 Aug; 36(8):3803-10. PubMed ID: 27466480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
